Allyson, Amine, Bharat, Dion, and Jean-Francois build outstanding healthcare companies as part of the largest and most active early-stage technology venture investor in Canada. The team invests in transformative companies that will disrupt the healthcare system, revolutionize care delivery, and improve patient health with innovative drugs and devices. The team manages $270 million in capital across different funds and is seeking investments in the drug, medical device, diagnostics, and digital health sectors.